Work

Abstract PS2-08-20: Translational analysis of cerebrospinal fluid (CSF) and plasma circulating tumor DNA (ctDNA) from breast cancer patients (pts) with leptomeningeal disease (LMD) treated with trastuzumab deruxtecan (T-DXd) in the DEBBRAH trial

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps2-08-20

Authors: A. Fitzpatrick, T. Shanmugalingam, S. Haider, M. Iravani, L. Garrigós, J. García-Sáenz, P. Cortez, F. Racca, S. Blanch, M. Ruiz-Borrego, G. Martrat, M. Mancino, J. Guerrero, J. Pérez-García, M. Vaz Batista, S. Braga, A. Llombart-Cussac, J. Cortés

Institutions: King's College London, Hospital Universitario Dexeus, Hospital Clínico San Carlos, Fundación Instituto Valenciano de Oncología, Hospital Universitario Virgen del Rocío, MedSIR (Spain), Universidad Cardenal Herrera CEU, Hospital Arnau de Vilanova, Hospital Universitario de Torrejón, Universidad Europea de Madrid

Language: English

Topic: Brain Metastases and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7130713486

Cites:

Cited by:

Related to: